The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial

The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial

Background: Restless legs syndrome (RLS) affects approximately 30% of patients with end-stage kidney disease and is associated with impaired sleep and health-related quality of life. Medications used to treat RLS in patients receiving dialysis may have an increased risk of adverse events with dose t...

Full description

Bibliographic Details
Main Authors: David Collister, Kayla Pohl, Gwen Herrington, Shun Fu Lee, Christian Rabbat, Karthik Tennankore, Deborah Zimmermann, Navdeep Tangri, Ron Wald, Braden Manns, Rita S. Suri, Annie-Claire Nadeau-Fredette, Remi Goupil, Samuel A. Silver, Michael Walsh
Format: Article
Language:English
Published: SAGE Publishing 2020-11-01
Series:Canadian Journal of Kidney Health and Disease
Online Access:https://doi.org/10.1177/2054358120968959

Internet

https://doi.org/10.1177/2054358120968959

Similar Items